Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 7, 2005, Pages 833-836

  Dale, James B ^a,e   Penfound, Thomas ^a   Chiang, Edna Y ^a   Long, Valerie ^a   Shulman, Stanford T ^b,c   Beall, Bernard ^d  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c CHILDREN'S MEMORIAL HOSPITAL   (United States)

^d NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL PROTEIN M; EPITOPE; GROUP A STREPTOCOCCAL VACCINE; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG EFFICACY; EPIDEMIOLOGICAL DATA; IMMUNIZATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SEROTYPE; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS GROUP A M1; STREPTOCOCCUS GROUP A M3; STREPTOCOCCUS GROUP A M5;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; EPITOPES; MOLECULAR SEQUENCE DATA; RABBITS; SERUM BACTERICIDAL TEST; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS;

EID: 22244493238     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.7.833-836.2005     Document Type: Article

References (13)

1. Beres, S. B., G. L. Sylva, D. E. Sturdevant, C. N. Granville, M. Liu, S. M. Ricklefs, A. R. Whitney, L. D. Parkins, N. P. Hoe, G. J. Adams, D. E. Low, K. R. DeLeo, A. McGeer, and J. M. Musser. 2004. Genome-wide molecular dissection of scrotype M3 group A Streptococcus strains causing two epidemics of invasive infections. Proc. Natl. Acad. Sci. USA 101:11833-11838.
2. Dale, J. B., M. Simmons, E. C. Chiang, and E. Y. Chiang. 1996. Recombinant, octavalent group A streptococcal M protein vaccine. Vaccine 14:944-948.
3. de Malmanche, S. A., and D. R. Martin. 1994. Protective immunity to the group A Streptococcus may be only strain specific. Med. Microbiol. Immunol. 183:299-306.
4. Facklam, R., B. Beall, A. Efstratiou, V. Fischetti, D. Johnson, E. Kaplan, P. Kriz, M. Lovgren, D. Martin, B. Schwartz, A. Totolian, D, Bessen, S. Hollingshead, F. Rubin, J. Scott, and G. Tyrrell. 1999. cmm typing and validation of provisional M types for group A streptococci. Emerg. Infect. Dis. 5:247-253.
5. Hu, M., M. Walls, S. Stroop, M. Reddish, B. Beall, and J. Dale. 2002. Immunogenicity of a 26-valcnt group A streptococcal vaccine. Infect. Immun. 70:2171-2177.
6. Lancefield, R. C. 1962. Current knowledge of the type specific M antigens of group A streptococci. J. Immunol. 89:307-313.
7. Lancefield, R. C. 1957. Differentiation of group A streptococci with a common R antigen into three serologic types with special reference to the bactericidal test. J. Exp. Med. 106:525-544.
8. Lancefield, R. C. 1959. Persistence of type-specific antibodies in man following infection with group A streptococci. J. Exp. Med. 110:271-292.
9. Li, Z., V. Sakota, D. Jackson, A. R. Franklin, and B. Beall. 2003. Array of M protein gene subtypes in 1064 recent invasive group A streptococcus isolates recovered from the active bacterial core surveillance. J. Infect. Dis. 188: 1587-1592.
10. McNeil, S. A., S. A. Halperin, J. Langley, B. Smith, A. Warren, D. Baxendale, M. A. Reddish, M. C. Hu, S. D. Stroop, M. A. Walls, J. Linden, G. H. Lowell, L. F. Fries, P. Vink, and J. B. Dale. Safety and immunogenicity of a 26-valent group A streptococcus vaccine in healthy adult volunteers. Clin. Infect. Dis., in press.
11. O'Brien, K. L., B. Beall, N. L. Barrett, P. R. Cieslak, A. Reingold, M. M. Parley, R. Danila, E. R. Zell, R. Facklam, B. Schwartz, and A. Schuchat. 2002. Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clin. Infect. Dis. 35:268-276.
12. Shulman, S. T., R. R. Tanz, W. Kabat, K. Kabat, E. Cederlund, D. Patel, Z. Li, V. Sakota, J. B. Dale, and B. Beall. 2004. Group A streptococcal pharyngitis serotypc surveillance in North America, 2000-2002. Clin. Infect. Dis. 39:325-332.
13. Villasenor-Sierra, A., W. M. McShan, D. Salmi, E. L. Kaplan, D. R. Johnson, and D. L. Stevens. 1999. Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera. J. Infect. Dis. 180:1921-1928.